
June 30, 2023
RegMed Investors’ (RMi) closing bell: the oxygen machine was turned back on so the sector could climb the wall of worry
June 30, 2023
RegMed Investors’ (RMi) pre-open: will the oxygen get sucked out of the sector?
June 29, 2023
RegMed Investors’ (RMi) closing bell: a stress test of cell and gene therapy sector defines its equities
June 29, 2023
RegMed Investors’ (RMi) pre-open: willing to stay or sell into strength and make with a profit and come back another session
June 28, 2023
RegMed Investors’ (RMi) closing bell: it ain’t over, sentiment is testing resistance
June 27, 2023
RegMed Investors’ (RMi) closing bell: I told you yesterday, the cell and gene therapy sector would come back
June 27, 2023
RegMed Investors’ (RMi) pre-open: uncle algorithm, please check out the cell and gene therapy underdogs
June 26, 2023
RegMed Investors’ (RMi) closing bell: cell and gene therapy sector gets ditched again
June 26, 2023
RegMed Investors’ (RMi) pre-open: tip-toe into the sector in Q and June’s final week
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors